Atlas Bio simplifies the discovery of nonclinical precedents by organizing evidence from FDA and EMA regulatory reviews. Researchers can investigate toxicology findings, first-in-human dosing approaches, relevant animal models, and potential safety risks. With practical research guides and pre-IND readiness checklists, the platform supports evidence-based planning and regulatory preparation for innovative therapies.